BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.38 Increased By ▲ 0.06 (0.95%)
BECO 4.35 Increased By ▲ 0.08 (1.87%)
BML 62.55 Increased By ▲ 0.10 (0.16%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.73 Increased By ▲ 0.14 (1.21%)
CSIL 5.91 Increased By ▲ 0.19 (3.32%)
FCCL 61.71 Increased By ▲ 0.17 (0.28%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.32 Increased By ▲ 0.06 (0.96%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.69 Increased By ▲ 0.01 (0.04%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.32 Decreased By ▼ -1.96 (-1.12%)
NCPL 51.83 Decreased By ▼ -0.94 (-1.78%)
NPL 54.03 Decreased By ▼ -0.09 (-0.17%)
OGDC 315.87 Increased By ▲ 2.48 (0.79%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.58 Decreased By ▼ -0.22 (-0.61%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 226.07 Increased By ▲ 4.26 (1.92%)
PRL 80.28 Increased By ▲ 1.20 (1.52%)
PTC 46.64 Decreased By ▼ -0.21 (-0.45%)
SSGC 23.82 Decreased By ▼ -0.05 (-0.21%)
TBL 9.24 Decreased By ▼ -0.07 (-0.75%)
TELE 7.55 Increased By ▲ 0.16 (2.17%)
TPL 24.54 Decreased By ▼ -0.57 (-2.27%)
TPLP 12.99 Increased By ▲ 0.48 (3.84%)
TREET 25.98 Decreased By ▼ -0.27 (-1.03%)
TRG 53.33 Decreased By ▼ -0.11 (-0.21%)

GENEVA: The World Health Organization on Thursday unveiled a new strategy to dramatically cut deaths and injuries from snakebites, warning a dearth of antivenoms could soon spark a "public health emergency".

Each year, nearly three million people are bitten by poisonous snakes, with an estimated 81,000-138,000 deaths. Another 400,000 survivors suffer permanent disabilities and other after-effects, according to WHO figures.

In a new report, the UN health agency urged the international community to take steps to address the problem, which it warned had long been dangerously under-estimated and neglected.

WHO, which two years ago categorised "snakebite envenoming" as a Neglected Tropical Disease, presented a strategy aimed at cutting snakebite-related deaths and disabilities in half by 2030.

Snake venom can cause paralysis that stops breathing, bleeding disorders that can lead to fatal haemorrhage, irreversible kidney failure and tissue damage that can cause permanent disability and limb loss.

Most snakebite victims live in the world's tropical and poorest regions, and children are worse affected due to their smaller body size.

An important part of the strategy is to significantly boost production of quality antivenoms, WHO said.

Production of life-saving antivenoms has been abandoned by a number of companies since the 1980s, and availability of effective and safe products is disastrously low in Africa especially, with a similar crisis also looming in Asia.

"Without urgent reshaping of the market, greater regulatory control and other measures, a public health emergency is imminent," the WHO report warned.

The UN agency called for "the restoration of a sustainable market for snakebite treatment", insisting on the need for a 25-percent increase in the number of competent manufacturers by 2030.

WHO said it planned a pilot project to create a global antivenom stockpile.

The strategy also called for integrating snakebite treatment and response into national health plans in affected countries, including better training of health personnel and educating communities.

The Doctors Without Borders charity praised the strategy, saying it "could be a turning point" in tackling snakebite poisoning, which it said "kills more people than any other disease on WHO's Neglected Tropical Diseases list."

"The toll that snakebite envenoming takes on people around the world truly represents a hidden epidemic," MSF Tropical Medicine Advisor Gabriel Alcoba said in a statement.

Copyright AFP (Agence France-Press), 2019
 

Comments

Comments are closed for this article.